The University of Manchester

Research output

Research output per year 1954 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 3023

• 165760 Article
• 25395 Conference contribution
• 19623 Chapter
• 5081 Book
• 27936 More
  • 3771 Commissioned report
  • 2670 Review article
  • 1988 Paper
  • 1915 Poster
  • 1902 Other
  • 1526 Other contribution
  • 1322 Anthology
  • 1292 Working paper
  • 1222 Letter
  • 1214 Editorial
  • 1072 Comment/debate
  • 957 Meeting Abstract
  • 891 Book/Film/Article review
  • 868 Entry for encyclopedia/dictionary
  • 795 Doctoral Thesis
  • 665 Abstract
  • 541 Scholarly edition
  • 520 Patent
  • 395 Foreword/postscript
  • 387 Conference article
  • 290 Other report
  • 263 Master's Thesis
  • 227 Preprint
  • 216 Composition
  • 182 Exhibition
  • 171 Special issue
  • 103 Digital or Visual Products
  • 93 Literature review
  • 82 Other chapter contribution
  • 74 Data set/Database
  • 73 Web publication/site
  • 71 Short survey
  • 60 Performance
  • 58 Discussion paper
  • 28 Software
  • 17 Featured article
  • 14 Artefact
  • 1 Design

Research output per year

Research output per year

Search results

• 2023

  11MO Final data from a phase II study (TACTI-002) of eftilagimod alpha (soluble LAG-3) and pembrolizumab in 2nd-line metastatic NSCLC pts resistant to PD-1/PD-L1 inhibitors

  Majem, M., Forster, M. D., Krebs, M., Peguero, J., Clay, T., Felip, E., Iams, W., Roxburgh, P., Spéville, B., Bajaj, P., Mueller, C. & Triebel, F., 1 Apr 2023, (E-pub ahead of print) In: Journal of Thoracic Oncology. 18, p. S43-S44

  Research output: Contribution to journal › Meeting Abstract › peer-review

• 124MO A single centre experience of patients with rare cancers referred for early phase clinical trials

  Angelakas, A., Cook, N., Graham, D. M., Krebs, M., Thistlethwaite, F. & Carter, L., 22 Mar 2023, In: ESMO Open. 8, 1

  Research output: Contribution to journal › Meeting Abstract › peer-review

• 42621 Biosimilars in the treatment of psoriasis – A systematic review of evidence from randomized controlled trials and real-world data

  Phan, D. B., Warren, R., Lunt, M. & Yiu, Z., 2023, In: Journal of the American Academy of Dermatology. 89, 3

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Abstract CT029: Phase Ib study of GDC-6036 in combination with cetuximab in patients with colorectal cancer (CRC) with KRAS G12C mutation

  Desai, J., Han, S-W., Lee, J-S., Shacham-Shmueli, E., Massarelli, E., Cervantes, A., Garralda, E., Falcon, A., Miller, W. H., Gort, E., Karasic, T., Siena, S., Stec, R., Medina, L., Paz-Arez, L., Delmonte, A., Sacher, A., Prenen, H., Forster, M., Kim, T. W., & 11 othersKrebs, M. G., Cosman, R., Choi, Y., Mandlekar, S., Lin, M. T., Yau, K. K., Chang, J., Royer-Joo, S., Dharia, N. V., Schutzman, J. L. & Patel, M., 14 Apr 2023, In: Cancer Research. 83, 8_Supplement, p. CT029-CT029

  Research output: Contribution to journal › Meeting Abstract › peer-review

  • Inpatient 100%
  • Colorectal Cancer 100%
  • Patient 100%
  • Cetuximab 100%
  • Therapeutic Procedure 26%

• Baricitinib Effectiveness After a Previous Inadequate Response to an Alternative Jak Inhibitor: Results From the Swiss Rheumatoid Arthritis Register (scqm-ra)

  Gilbert, B., Courvoisier, DS., Mongin, D., Lauper, K., Guimaraes, VA., Mueller, RB., Finckh, A. & Pile, K., Apr 2023, In: Internal Medicine Journal. 53, p. 36-36 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Bemcentinib and pembrolizumab in patients with relapsed mesothelioma: MIST3, a phase IIa trial with cellular and molecular correlates of efficacy.

  Krebs, M., Branson, A., Barber, S., Poile, C., King, A., Greystoke, A., Moody, S., Nolan, L., Scotland, M., Darlison, L., Bajaj, A., Morgan, B., Brookes, C., Wells-Jordan, P., Richards, C., Thomas, A. & Fennell, D., 1 Jun 2023, In: Journal of Clinical Oncology. 41, 16_suppl, p. 8511 1 p.

  Research output: Contribution to journal › Meeting Abstract

  Open Access

  • Bemcentinib 100%
  • Patient 100%
  • Pembrolizumab 100%
  • Mesothelioma 100%
  • Inpatient 100%

• Clinical practice innovation: pre-treatment with intragastric balloon vs. GLP-1 injections prior to bariatric surgery for patients with severe obesity

  Slater, C., Ellison, J., Weerasinghe, P., Rigor, M., Majeed, W., Mudaliar, R., Alkhaffaf, B., Sultan, J., Senapati, S., Akhtar, K. & Syed, A., Jul 2023, In: Obesity Surgery. 33, p. S124-S124 1 p.

  Research output: Contribution to journal › Meeting Abstract

  • Injection 100%
  • Glucagon Like Peptide 1 100%
  • Patient 100%
  • Therapeutic Procedure 100%
  • Obesity 100%

• Concurrent left ventricular myocardial diffuse fibrosis and left atrial dysfunction strongly predicts incident heart failure and all-cause mortality

  Aung, N., Wong, MYZ., Vargas, JD., Naderi, H., Sanghvi, MM., Raisi-Estabragh, Z., Suinesiaputra, A., Bonazzola, R., Attar, R., Ravikumar, N., Hann, E., Neubauer, S., Piechnik, SK., Frangi, AJ. & Petersen, SE., Feb 2023, In: European Heart Journal . 44, p. 11-11 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Deaths of despair in England: an observational study of local authority mortality data

  Camacho, C., Webb, R. T., Bower, P. & Munford, L., 23 Nov 2023, (E-pub ahead of print) In: The Lancet. 402, Supplement 1, p. S31

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

  File

  • Ethnicity 100%
  • Employment 100%
  • Economics 100%
  • Accounting 100%
  • Knowledge 100%

• Diagnosis of Cushing's in the presence of unilateral adrenal adenoma: not always what it seems

  ying, K. X., Majeed, W. & Syed, A., 1 Apr 2023, In: Endocrine Abstracts. 91

  Research output: Contribution to journal › Meeting Abstract

  Open Access

• Equality, Diversity & Inclusion in the Workplace: Exploring the Experiences of Psychiatry Trainees Across the North West of England

  Hosein, C., Sparasci, O., dos, S. C. & Inkster, C., 7 Jul 2023, In: BJPsych Open.

  Research output: Contribution to journal › Meeting Abstract

  • Experience 100%
  • Psychiatry 100%
  • Diversity 100%
  • Students 100%
  • Workplace 100%

• Feasibility study of an electronic health record-based gout registry

  Burgisser, N., Mongin, D., Farhoumand, PD., Braillard, O., Lauper, K. & Courvoisier, DS., 28 Aug 2023, In: Swiss Medical Weekly. 153, p. 15S-15S 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Final results from TACTI-002 Part C: A phase II study of eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab in patients with metastatic 2nd line head and neck squamous cell carcinoma unselected for PD-L1.

  Spéville, B., Felip, E., Forster, M., Majem, M., Bajaj, P., Peguero, J., Carcereny, E., Krebs, M., Mukherjee, U., Mueller, C. & Triebel, F., 1 Jun 2023, In: Journal of Clinical Oncology. 41, 16_suppl, p. 6029 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

  • Pembrolizumab 100%
  • Inpatient 100%
  • Protein 100%
  • Programmed Death-Ligand 1 100%
  • Head and Neck Squamous Cell Carcinoma 100%

• Heterogeneity in major cardiovascular events assessment between countries participating in an international collaboration of 20 registers of rheumatoid arthritis patients using Janus Kinase Inhibitors (the "JAK-pot" study)

  Guemara, R., Aymon, R., Askling, J., Bergstra, SA., Choquette, D., Codreanu, C., Cordtz, RL., Dalkilic, E., De Cock, D., Dreyer, L., Elkayam, O., Huscheck, D., Hyrich, KL., Iannone, F., Inanc, N., Kearsley-Fleet, L., Kvien, TK., Leeb, B., Lukina, G., Nordström, D., & 12 othersPavelka, K., Pombo-Suarez, M., Provan, SA., Rodrigues, AM., Rotar, Z., Strangfeld, A., Verschueren, P., Zavada, J., Courvoisier, D., Finckh, A., Mongin, D. & Lauper, K., 28 Aug 2023, In: Swiss Medical Weekly. 153, p. 6S-7S 2 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: data from an international collaboration of registries (the "JAK-pot" study)

  Aymon, R., Mongin, D., Bergstra, SA., Choquette, D., Codreanu, C., Cordtz, RL., De Cock, D., Dreyer, L., Elkayam, O., Huschek, D., Hyrich, KL., Iannone, F., Inanc, N., Kearsley-Fleet, L., Kvien, TK., Leeb, BF., Lukina, G., Nordström, D., Onen, F., Pavelka, K., & 10 othersPombo-Suarez, M., Provan, S., Rodrigues, AM., Rotar, Z., Strangfeld, A., Verschueren, P., Zavada, J., Courvoisier, D., Finckh, A. & Lauper, K., 28 Aug 2023, In: Swiss Medical Weekly. 153, p. 2S-2S 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Intracranial and systemic efficacy of repotrectinib in advanced ROS1 fusion-positive ( ROS1 +) non-small cell lung cancer (NSCLC) and central nervous system metastases (CNS mets) in the phase 1/2 TRIDENT-1.

  Lin, J., Drilon, A., Cho, B., Felip, E., Langen, A., Yang, N., Kim, S-W., Lu, S., Kao, S., Velcheti, V., Sibilot, D., Solomon, B., Dziadziuszko, R., Krebs, M., Cheema, P., Dooms, C., Stopatschinskaja, S., Trone, D., Ades, F. & Camidge, D., 1 Jun 2023, In: Journal of Clinical Oncology. 41, 16_suppl, p. 9017 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

  • Non Small Cell Lung Cancer 100%
  • Tyrosine-Kinase Inhibitor 100%
  • Central Nervous System Metastasis 100%
  • Protein Tyrosine Kinase Inhibitor 100%
  • Central Nervous System 100%

• Long-term comparative observational study of effectiveness of bariatric surgery in people with or without metabolic syndrome

  Ragavan, S., Elhelw, O., Majeed, W., Alkhaffaf, B., Senapati, S. & Syed, A., Jul 2023, In: Obesity Surgery. 33, p. S22-S22 1 p.

  Research output: Contribution to journal › Meeting Abstract

  • Metabolic Syndrome 100%
  • Surgery 100%
  • Observational Study 100%
  • Obesity 100%

• Long-term observational study of the effect of bariatric surgery on liver enzymes in people with obesity

  Elhelw, O., Ragavan, S., Majeed, W., Alkhaffaf, B., Senapati, S. & Syed, A., Jul 2023, In: Obesity Surgery. 33, p. S21-S21 1 p.

  Research output: Contribution to journal › Meeting Abstract

  • Obesity 100%
  • Observational Study 100%
  • Liver Enzyme 100%
  • Bariatric Surgery 100%
  • Lysozyme 100%

• MO-0467 Impact of the COVID-19 pandemic on patient outcomes after curative-intent radiotherapy in the UK

  Fornacon-Wood, I., Banfill, K., Ahmad, S., Britten, A., Carson, C., Dorey, N., Hatton, M., Hiley, C., Thippu Jayaprakash, K., Jegannathen, A., Koh, P., Panakis, N., Peedell, C., Pope, A., Powell, C., Stilwell, C., Thomas, B., Toy, E., Wicks, K., Wood, V., & 4 othersYahya, S., Peters, A., Price, G. & Faivre-Finn, C., May 2023, In: Radiotherapy and Oncology. 182, p. S370-S371

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Myeloperoxidase-derived Oxidised Lipids in Type 2 Diabetes

  Shokr, H., Abdelmohimen, Y. & Dias, I. H., 20 May 2023, In: Free Radical Biology and Medicine. 201, p. 16-16 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• P13 Prediction and in vitro characterization of tetrapeptide matrikines with diverse effects on human dermal fibroblasts

  Jariwala, N., Ozols, M., Eckersley, A., Watson, R., Mambwe, B., Gilmore, A., Debelle, L., Bell, M., Bradley, E., Doush, Y., Leroux, R., Peschard, O., Mondon, P., Ringenbach, C., Bernard, L., Pitois, A. & Sherratt, M., 7 Jul 2023, In: British Journal of Dermatology. 189, 1, p. E18-E19 2 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• PII-059* Mechanistic Population Pharmacokinetic Modeling of Risdiplam for Extrapolation of Exposure and Cyp3a Drug-drug Interaction in Neonates with Spinal Muscular Atrophy

  Cleary, Y., Kletzl, H., Grimsey, P., Heinig, K., Ogungbenro, K., Silber--Baumann, H., Frey, N., Aarons, L., Galetin, A. & Gertz, M., 1 Mar 2023, In: Clinical Pharmacology & Therapeutics. 113, p. S63 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Predicting Myocardial Infarction through Retinal Scans and Minimal Patient Information

  Frangi, AF., Jun 2023, In: Investigative ophthalmology & visual science. 64, 8, 2 p., 3280.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Quantifying preferences for watch-and-wait compared with surgery after a clinical complete response in rectal cancer: a discrete choice experiment

  Dalal, G., Wright, S., Malcomson, L., Renehan, A. & Payne, K., Mar 2023, In: Medical Decision Making. 43, 3, p. NP454-55

  Research output: Contribution to journal › Meeting Abstract › peer-review

  • Malignant Neoplasm 100%
  • Rectum Cancer 100%
  • Surgery 100%
  • Experiment 100%
  • Sample 77%

• Regional audit: timing of enteral nutrition in critical care in the North West over 10 days

  Blaikley, J., Dark, P. & Kitchen, G., 23 Jul 2023, In: Anaesthesia. 78, p. 7-7 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Risk of SARS-CoV-2 infection following 3-dose homologous BNT162b2 or mRNA-1273 in patients with inflammatory rheumatic diseases

  Raptis, CE., Polysopoulos, C., Berger, CT., Ciurea, A., Andrey, DO., Maletic, T., Riek, M., Scherer, A., Loga, V., Safford, J., Lauper, K., Moeller, B., Vuilleumier, N., Finckh, A. & Rubbert-Roth, A., 28 Aug 2023, In: Swiss Medical Weekly. 153, p. 11S-11S 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Subcutaneous amivantamab (ami) in patients (pts) with advanced solid malignancies: The PALOMA study—Updated safety and identification of the recommended phase 2 dose.

  Minchom, A., Krebs, M., Cho, B., Lee, S-H., Leighl, N., O'Neil, B., Sabari, J., Kudgus-Lokken, R., Alhadab, A., Haddish-Berhane, N., Zemlickis, D., Mitselos, A., Berkay, E., Bauml, J., Knoblauch, R., Hellemans, P. & Johnson, M., 1 Jun 2023, In: Journal of Clinical Oncology. 41, 16_suppl, p. 9126-9126 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

  • Infusion Related Reaction 100%
  • Recombinant Hyaluronidase 60%
  • Solid Malignant Neoplasm 40%
  • Pneumonia 20%
  • Fever 20%

• SUN-359 Describing the genetic architecture of hip shape: findings from UK Biobank

  Frysz, M., Faber, B. G., Ebsim, R., Saunders, FS., Gregory, JS., Aspden, RM., Harvey, NC., Lindner, C., Cootes, T., Kemp, JP. & Tobias, J. H., 1 Feb 2023, In: Journal of Bone and Mineral Research. 38, S1, p. 236 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• THE HIPHOP STUDY: A FEASIBILITY STUDY FOR A RANDOMIZED CONTROLLED TRIAL OF HYBRID VERSUS CEMENTED TOTAL HIP ARTHROPLASTY

  Board, T., Powell, R., Davies, A., Coffey, T., Wylde, V., Taylor, T., Hickey, H., Gornall, M., Jackson, R., Dalal, G., Eden, M., Wilson, M. & Divecha, H., 7 Jun 2023, In: Orthopaedic Proceedings. 105-B, SUPP_11, p. 34

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

• The Swinging Sixties: Drug-fuelled Highs and Lows

  Ying, K. X. & Syed, A., 1 Apr 2023, In: Endocrine Abstracts. 91

  Research output: Contribution to journal › Meeting Abstract

  Open Access

• Transdermal delivery of a hydrogen sulphide donor, AP39 using aqueous gel formulations in the treatment of neurological dysfunction

  Marwah, M., Ahmad, S., Shokr, H., Dias, I. & Sanchez-Aranguren, L., Feb 2023, In: British Journal of Pharmacology. 180, 4, p. 541-542 2 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2022

  104 Impact of introducing intensity modulated radiotherapy (IMRT) on curative intent radiotherapy and survival for lung cancer

  Chan, C., Fornacon-Wood, I., Bayman, N., Banfil, K., Coote, J., Garbett, A., Harris, M., Hudson, A., Kennedy, J., Pemberton, L., Price, G., Salem, A., Sheikh, H., Whitehurst, P., Woolf, D. & Faivre-Finn, C., Mar 2022, In: Lung Cancer. 165, p. S49

  Research output: Contribution to journal › Meeting Abstract › peer-review

• 11P Results of a phase II study investigating eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab in second-line PD-1/PD-L1 refractory metastatic non-small cell lung carcinoma pts

  Krebs, M., Majem, M., Forster, M., Peguero, J. A., Clay, T., Felip, E., Iams, W., Roxburgh, P., Spéville, B., Bajaj, P., Mueller, C. & Triebel, F., 1 Apr 2022, In: Annals of Oncology. 33, p. S33

  Research output: Contribution to journal › Meeting Abstract › peer-review

• 20P Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC)

  Trigo, J., Cho, B. C., Park, K., Girard, N., Viteri, S., Garrido, P., Krebs, M., Thayu, M., Knoblauch, R. E., Xie, J., Bauml, J. M., Schnepp, R. W., Londhe, A., Mahadevia, P. & Leighl, N., 1 Apr 2022, In: Annals of Oncology. 33, p. S38-S39

  Research output: Contribution to journal › Meeting Abstract › peer-review

• 362P Phase Ia study to evaluate GDC-6036 monotherapy in patients with colorectal cancer (CRC) with KRAS G12C mutation

  Desai, J., Han, S-W., Forster, M. D., Kim, T. W., Casal, G., Shmueli, E., Bowyer, S. E., Miguel, M. J., Gonzalez, A., Jones, R., Krebs, M., Miller, W. H., Paz-Ares, L., Lorusso, P., Sacher, A., Dharia, N., Lin, M. T., Schutzman, J. L., Shi, Z. & Patel, M., 1 Sept 2022, In: Annals of Oncology. 33, p. S701-S702

  Research output: Contribution to journal › Meeting Abstract › peer-review

• 384P Concordance of genomic alterations in tumour tissue and ctDNA in patients with colorectal cancer referred for early phase trials

  Ramchander, N., Billy Graham Mariam, N., Rack, S., Shohdy, K., Franco, A., Thistlethwaite, F., Graham, D. M., Carter, L., Dransfield, S., Henshaw, A., Darlington, E., Rothwell, D., Burghel, G., Dive, C., Krebs, M. & Cook, N., 1 Sept 2022, In: Annals of Oncology. 33, p. S712

  Research output: Contribution to journal › Meeting Abstract › peer-review

• 459MO Phase Ia study to evaluate GDC-6036 monotherapy in patients with solid tumors with a KRAS G12C mutation

  Patel, M., Lee, J-S., Miguel, M. J., Burns, T., Gonzalez, A., Kim, T. W., Krebs, M., Prenen, H., Shmueli, E., Desai, J., Lorusso, P., Sacher, A., Choi, Y., Dharia, N., Lin, M. T., Mandlekar, S., Royer-Joo, S., Schutzman, J. L. & Garralda, E., 1 Sept 2022, In: Annals of Oncology. 33, p. S749

  Research output: Contribution to journal › Meeting Abstract › peer-review

• 777 Initial clinical characterization of novel proximal biomarkers for NX-1607, a first-in-class oral CBL-B inhibitor, in patients with advanced malignancies

  Whelan, S., Karim, C., Ye, J., Ingallinera, T., Cherala, G., Jameson, K., Williams, A., Sharp, A., Krebs, M., Pacey, S., Blagden, S., Plummer, R., Hochhauser, D., Evans, J., Bono, J. & Powers, J., 7 Nov 2022, In: Journal for ImmunoTherapy of Cancer. 10

  Research output: Contribution to journal › Meeting Abstract › peer-review

• A first-in-human phase 1 trial of nx-1607, a first-in-class oral CBL-B inhibitor, in patients with advanced solid tumor malignancies.

  Sharp, A., Williams, A., Blagden, S., Plummer, E., Hochhauser, D., Krebs, M., Pacey, S., Evans, J., Whelan, S., Nandakumar, S., Rogers, S., Jameson, K., Basile, F., Bono, J. & Arkenau, H-T., 1 Jun 2022, In: Journal of Clinical Oncology. 40, p. TPS2691-TPS2691

  Research output: Contribution to journal › Meeting Abstract › peer-review

• A History of Chlamydiae Infection in Rheumatoid Arthritis Development

  Lamacchia, C., Aymon, R., Gilbert, B., Studer, O., Lauper, K. & Finckh, A., Jun 2022, In: Annals of the rheumatic diseases. 81, p. 465-466 2 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Amivantamab in patients with NSCLC with MET exon 14 skipping mutation: Updated results from the CHRYSALIS study.

  Krebs, M., Spira, A., Cho, B., Besse, B., Goldman, J., Janne, P., Ma, Z., Mansfield, A., Minchom, A., Ou, S-H., Salgia, R., Wang, Z., Perez, C., Gao, G., Curtin, J., Roshak, A., Schnepp, R., Thayu, M., Knoblauch, R. & Lee, C., 1 Jun 2022, In: Journal of Clinical Oncology. 40, p. 9008 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• A phase II study (TACTI-002) in first-line metastatic non–small cell lung carcinoma investigating eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab: Updated results from a PD-L1 unselected population.

  Felip, E., Majem, M., Doger, B., Clay, T., Carcereny, E., Bondarenko, I., Peguero, J., Cobo-Dols, M., Forster, M., Ursol, G., Ledo, G., Vilà, L., Krebs, M., Iams, W., Mueller, C. & Triebel, F., 1 Jun 2022, In: Journal of Clinical Oncology. 40, p. 9003 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• A phase II study to evaluate the safety and efficacy of IMM-101 in combination with checkpoint inhibitors in patients with advanced melanoma: Final results of the IMM101-015 trial.

  Fusi, A., Gupta, A., Lorigan, P., Smith, PL. & Bowles, M., 1 Jun 2022, In: Journal of Clinical Oncology. 40, 16, 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Assessing the inter and intra-fraction changes utilising MR Linac for cervical cancer

  Alshamrani, A., Chuter, R., Nelder, C., Choudhury, A., Barraclough, L., Eccles, C., Aznar, M. & Hoskin, P., May 2022, In: Radiotherapy and Oncology. 170, p. S1644-S1645 2 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• A Systematic Review of Social Media Interventions Targeting Exercise and Diet Behaviours in People with Ncds

  McKeon, G., Papadopoulos, E., Firth, J. & Rosenbaum, S., 22 Apr 2022, In: Annals of Behavioral Medicine. 56, SUPP 1, p. S480-S480 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Automated AI-assisted diagnosis of active aortitis using radiomic analysis of FDG PET-CT imaging

  Duff, L., Scarsbrook, AF., Ravikumar, N., Frood, R., Mackie, SL., Bailey, M., Tarkin, JM., Mason, JC., Frangi, A. F., Morgan, AW. & Tsoumpas, C., Sept 2022, In: European Journal of Nuclear Medicine and Molecular Imaging. 49, SUPPL 1, p. S104-S105 2 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Checkpoint inhibitor associated bullous cutaneous adverse immune-related events: a multicentre observational study

  Kawsar, A., Edwards, C., Harwood, C. A., Matin, R., Lorigan, P., Harland, C., Patel, P., Heywood, R., Gupta, A., Mann, J., Heelan, K., Larkin, J. & Fearfield, L., Jul 2022, In: British Journal of Dermatology. 187, p. 18-18

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Circulating tumor DNA (ctDNA) determinants of improved outcomes in patients (pts) with advanced solid tumors receiving the ataxia telangiectasia and Rad3-related inhibitor (ATRi), RP-3500, in the phase 1/2a TRESR trial (NCT04497116).

  Rosen, E., Silverman, I. M., Fontana, E., Lee, E. K., Spigel, D. R., Højgaard, M., Lheureux, S., Mettu, N. B., Carneiro, B. A., Carter, L., Plummer, E. R., Schonhoft, J. D., Ulanet, D., Manley, P., Reis-Filho, J. S., Xu, Y., Rimkunas, V., Koehler, M. & Yap, T. A., 2 Jun 2022, In: Journal of Clinical Oncology. 40, 16_suppl, p. 3082-3082 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

  • Inpatient 100%
  • Circulating Tumor DNA 100%
  • Ataxia Telangiectasia 100%
  • Solid Malignant Neoplasm 100%
  • Ataxia Telangiectasia and Rad3 Related 100%

• CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC)

  Horne, A., Ali, A., Brown, S., Butterworth, K., Chalmers, A., Clipson, A., Collinson, F., Dive, C., Faivre-Finn, C., Forster, M., Franks, K., Gilbert, A., Hanna, G., Hannaway, N., Harrow, S., Hartley, J., Hiley, C., Jones, R., Kendall, J., Krebs, M., & 11 othersMallison, G., O’Connor, J., Oughton, J., Phillip, R., Rothwell, D., Salem, A., Sebag-Montefiore, D., Shaw, P., Walls, G., Young, R. & Greystoke, A., Mar 2022, In: Lung Cancer. 165, p. S69-S70

  Research output: Contribution to journal › Meeting Abstract › peer-review

• Considerations for the clinical implementation of MRI-guided ART for H&N and lung cancers

  Clough, A., Nelder, C., McDaid, L., Whiteside, L., Awofisoye, T., Freear, L., Berresford, J., Marchant, T., McPartlin, A., Crockett, C. B., Salem, A., Cobben, D. & Eccles, C., May 2022, In: Radiotherapy and Oncology. 170, p. S364-S366 4 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review